Skin Cancer Detection
Russak Dermatology Clinic is utilizing groundbreaking technology in private practice: DermTech’s Pigmented Lesion Assay – the newest scientific testing for pigmented lesions, also known as moles, beauty marks or freckles. This non-invasive breakthrough in skincancer detection allows us to be able to take a sample of skin cells using an adhesive patch. By utilizing these skin cells, we are able to analyze genetic material for the presence of specific genes commonly found in skin cancer. No cutting the skin, no unnecessary scarring. We can now biopsy fewer lesions while catching more melanomas, increasing early detection of skin cancer.
BOOK YOUR PROCEDURE!
DermTech
“Dermatology advancements have made way for some incredible diagnostic tools, such as painless Skin Biopsy for early Skin Cancer detection. I am honored to be one of the first physicians in New York City to utilize DermTech technology to analyze skin biopsy samples collected non-invasively using an adhesive patch rather than a scalpel “
FREQUENTLY ASKED QUESTIONS
HOW IS MELANOMA DETECTED?
Everyone is at risk for potentially developing melanoma, and regular full body skin exams are a must. In an effort to offer our patients the most effective care, we are pleased to offer the DermTech Pigmented Lesion Assay in our practice. DermTech is the latest smart technology for early melanoma detection used by dermatologists during a skin exam to test pigmented lesions and help analyze irregular moles without cutting the skin.
The Adhesive Patch Skin Biopsy Kit is designed to reliably collect stratum corneum tissues of the skin from nearly all locations of the body. This tissue can be subjected to a variety of analyses including protein, RNA, and DNA to detect early stages of skin cancer.
Cross section of human skin showing the stratum corneum layer of the epidermis. SEM X1,000
WHAT THECHNOLOGY IS USED?
DermTech uses the tools of molecular biology to analyze skin cell samples collected non-invasively using an adhesive patch. The test gives us information on whether it is necessary to take further action, or if the mole is completely benign and nothing to worry about. It’s quick, non-invasive and painless for patients.
